🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Controlled, Sequ...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-06
Trial ID
NCT02485769
Treatments Being Tested
This is a Phase I study to investigate the safety and tolerability of AZD48...
Status
Completed
Location
Research Site
Start Date
2017-05-15
Trial ID
NCT03136991
The purpose of this 3 part study are; Part 1: to investigate the pharmacoki...
Status
Completed
Location
PRA Health Sciences
Start Date
2018-08-28
Trial ID
NCT03649997
Treatments Being Tested
The primary purpose of this study is to evaluate the safety, tolerability a...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-08
Trial ID
NCT01202266
This is a Phase I, first-in-human (FIH) study to assess the safety, tolerab...
Status
Terminated
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02712372
Treatments Being Tested
This is a study in Japanese healthy volunteers to determine the safety and ...
Status
Completed
Location
Research site
Start Date
2010-11
Trial ID
NCT01217905
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, PK and P...
Status
Completed
Location
California Clinical Trials Medical Group, Inc
Start Date
2015-07
Trial ID
NCT02509117
The purpose of this study is to assess the safety and tolerability of AZD16...
Status
Completed
Location
Research Site
Start Date
2009-05
Trial ID
NCT00916604
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Completed
Location
Centre for Clinical Studies
Start Date
2019-09-16
Trial ID
NCT03993704
Treatments Being Tested